Mead Johnson Nutrition
In David Rolfe's portfolio · Wedgewood Partners
Ticker MJN
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Wedgewood Partners 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2017 | Sell | 0 | |
| Q4 2016 | Reduce 15% | 1,451,913 | 2.5% |
| Q3 2016 | Reduce 34% | 1,714,019 | 2.8% |
| Q2 2016 | Reduce 10% | 2,583,720 | 4.8% |
| Q1 2016 | Reduce 9% | 2,859,884 | 4.4% |
| Q4 2015 | Reduce 10% | 3,137,622 | 4.3% |
| Q3 2015 | Add 28% | 3,497,161 | 3.6% |
| Q2 2015 | Add 5% | 2,730,152 | 3.3% |
| Q1 2015 | Reduce 1% | 2,594,166 | 3.5% |
| Q4 2014 | Add 9% | 2,615,792 | 3.5% |
| Q3 2014 | Add 1% | 2,394,115 | 3.7% |
| Q2 2014 | Add 3% | 2,381,845 | 3.9% |
| Q1 2014 | Buy | 2,315,336 | 3.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.